Masashi Mizumoto1,2, Hidetsugu Nakayama3, Mari Tokita4, Shinji Sugahara3, Haruko Hashii3, Takeji Sakae3, Koji Tsuboi3, Hideyuki Sakurai3, Koichi Tokuuye3,5. 1. Proton Medical Research Center, University of Tsukuba, Ibaraki, Japan. mizumoto1717@hotmail.com. 2. Proton Medical Research Center, University of Tsukuba, Tennoudai, Tsukuba, Ibaraki, 305-8575, Japan. mizumoto1717@hotmail.com. 3. Proton Medical Research Center, University of Tsukuba, Ibaraki, Japan. 4. Alpert Medical School of Brown University, Providence, RI, USA. 5. Department of Radiology, Tokyo Medical University, Tokyo, Japan.
Abstract
PURPOSE: To investigate technical feasibilities of noncoplanar proton-beam therapy (PBT) on dose reduction to critical organs. MATERIAL AND METHODS: The degree of mechanical precision, rotational limitations of the gantry and the treatment couch were evaluated, and dose-volume histograms were compared for noncoplanar and coplanar PBT. Following these studies, three patients with tumors proximal to the optic nerve underwent noncoplanar PBT. RESULTS: Noncoplanar PBT offered advantage in dose reduction to the optic nerve when compared to coplanar therapy. This advantage was more significant if the tumor reduced in size during treatment. None experienced radiation injury to the optic nerve during a short follow-up time of 7-12 months. CONCLUSION: Noncoplanar PBT appears to reduce doses to organs at risk.
PURPOSE: To investigate technical feasibilities of noncoplanar proton-beam therapy (PBT) on dose reduction to critical organs. MATERIAL AND METHODS: The degree of mechanical precision, rotational limitations of the gantry and the treatment couch were evaluated, and dose-volume histograms were compared for noncoplanar and coplanar PBT. Following these studies, three patients with tumors proximal to the optic nerve underwent noncoplanar PBT. RESULTS: Noncoplanar PBT offered advantage in dose reduction to the optic nerve when compared to coplanar therapy. This advantage was more significant if the tumor reduced in size during treatment. None experienced radiation injury to the optic nerve during a short follow-up time of 7-12 months. CONCLUSION: Noncoplanar PBT appears to reduce doses to organs at risk.
Authors: Robert Cardinale; Minhee Won; Ali Choucair; Michael Gillin; Arnab Chakravarti; Christopher Schultz; Luis Souhami; Allan Chen; Huong Pham; Minesh Mehta Journal: Int J Radiat Oncol Biol Phys Date: 2006-06-05 Impact factor: 7.038
Authors: M Fuss; E B Hug; R A Schaefer; M Nevinny-Stickel; D W Miller; J M Slater; J D Slater Journal: Int J Radiat Oncol Biol Phys Date: 1999-12-01 Impact factor: 7.038
Authors: Damien C Weber; Alexei V Trofimov; Thomas F Delaney; Thomas Bortfeld Journal: Int J Radiat Oncol Biol Phys Date: 2004-04-01 Impact factor: 7.038
Authors: W H St Clair; J A Adams; M Bues; B C Fullerton; Sean La Shell; H M Kooy; J S Loeffler; N J Tarbell Journal: Int J Radiat Oncol Biol Phys Date: 2004-03-01 Impact factor: 7.038
Authors: M Mizumoto; H Hashii; M Senarita; S Sakai; T Wada; T Okumura; K Tsuboi; H Sakurai Journal: Strahlenther Onkol Date: 2013-02-28 Impact factor: 3.621
Authors: Katsura Kosaki; Swantje Ecker; Daniel Habermehl; Stefan Rieken; Oliver Jäkel; Klaus Herfarth; Jürgen Debus; Stephanie E Combs Journal: Radiat Oncol Date: 2012-03-22 Impact factor: 3.481